Patent holdings for IPC class A61K 31/683

Total number of patents in this class: 539

10-year publication summary

44
54
63
56
58
54
42
21
30
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
1951
30
Achillion Pharmaceuticals, Inc.
168
24
N.V. Nutricia
1039
22
Aker Biomarine Human Ingredients AS
84
18
SignPath Pharma Inc.
67
16
Société des Produits Nestlé S.A.
9238
9
Acasti Pharma Inc.
11
6
Nutritional Therapeutics, Inc.
17
6
Tasly Pharmaceutical Group Co., Ltd.
115
6
Viking Therapeutics, Inc.
43
6
Kao Corporation
4903
5
Nippon Suisan Kaisha, Ltd.
200
5
SRX Cardio, LLC
21
5
Janssen Sciences Ireland Unlimited Company
435
5
Merck Sharp & Dohme LLC
3744
5
Arctic Bioscience AS
7
5
Tecton Bg, Inc.
7
5
Johnson & Johnson Vision Care, Inc.
1220
4
F. Hoffmann-La Roche AG
7939
4
Attillaps Holdings
14
4
Other owners 349